Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap50.21K
Market cap50.21K
Price-Earnings ratio0.01
Price-Earnings ratio0.01
Dividend yield—
Dividend yield—
Average volume15.55K
Average volume15.55K
High today$0.0012
High today$0.0012
Low today$0.0012
Low today$0.0012
Open price$0.0012
Open price$0.0012
Volume150.00
Volume150.00
52 Week high$0.556
52 Week high$0.556
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 50.21K, Carisma Therapeutics(CARM) trades at $0.00. The stock has a price-to-earnings ratio of 0.01.
On 2026-08-22, Carisma Therapeutics(CARM) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 150, compared to an average daily volume of 15.55K.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $0.56 and a low of $0.00.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $0.56 and a low of $0.00.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.